Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia

Will J. Cronenwett; John G. Csernansky

doi:10.1016/j.biopsych.2013.07.007

Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia

Will J. Cronenwett^*, John G. Csernansky

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	396-397
Number of pages	2
Journal	Biological psychiatry
Volume	74
Issue number	6
DOIs	https://doi.org/10.1016/j.biopsych.2013.07.007
State	Published - Sep 15 2013

Funding

Dr. Cronenwett has received research funding from Novartis Inc., Sunovion Pharmaceuticals Inc., Otsuka Pharmaceuticals Inc., and Naurex Inc. Dr. Csernansky has received consulting fees for service on a data monitoring committee for Eli Lilly and Co.

ASJC Scopus subject areas

Biological Psychiatry

Access to Document

10.1016/j.biopsych.2013.07.007

Cite this

@article{4562a24b56d34f18bd5a673acc4c1c88,

title = "Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia",

author = "Cronenwett, {Will J.} and Csernansky, {John G.}",

note = "Funding Information: Dr. Cronenwett has received research funding from Novartis Inc., Sunovion Pharmaceuticals Inc., Otsuka Pharmaceuticals Inc., and Naurex Inc. Dr. Csernansky has received consulting fees for service on a data monitoring committee for Eli Lilly and Co.",

year = "2013",

month = sep,

day = "15",

doi = "10.1016/j.biopsych.2013.07.007",

language = "English (US)",

volume = "74",

pages = "396--397",

journal = "Biological psychiatry",

issn = "0006-3223",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia

AU - Cronenwett, Will J.

AU - Csernansky, John G.

N1 - Funding Information: Dr. Cronenwett has received research funding from Novartis Inc., Sunovion Pharmaceuticals Inc., Otsuka Pharmaceuticals Inc., and Naurex Inc. Dr. Csernansky has received consulting fees for service on a data monitoring committee for Eli Lilly and Co.

PY - 2013/9/15

Y1 - 2013/9/15

UR - http://www.scopus.com/inward/record.url?scp=84882672032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882672032&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2013.07.007

DO - 10.1016/j.biopsych.2013.07.007

M3 - Comment/debate

C2 - 23968985

AN - SCOPUS:84882672032

SN - 0006-3223

VL - 74

SP - 396

EP - 397

JO - Biological psychiatry

JF - Biological psychiatry

IS - 6

ER -

Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this